Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2014
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact
Helen Rizos, Alexander M Menzies, Gulietta M Pupo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2017
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, et al.
JCO Precision Oncology
|
March 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study
Andrea Boutros, Matteo S Carlino, Raja Chaganti, et al.
Molecular Cancer Research : MCR
|
March 6, 2019
Somatic Hypermutation of the <i>YAP</i> Oncogene in a Human Cutaneous Melanoma
Xiaomeng Zhang, Jian Zhong Tang, Ismael A Vergara, et al.
Cancers
|
December 5, 2019
Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
Russell J Diefenbach, Jenny H Lee, Dario Strbenac, et al.
Science Signaling
|
August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
Oncotarget
|
November 3, 2015
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Elin S Gray, Helen Rizos, Anna L Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2020
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
Jenny H Lee, Alexander M Menzies, Matteo S Carlino, et al.
Cancer Research
|
October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma
Y N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2014
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact
Helen Rizos, Alexander M Menzies, Gulietta M Pupo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2017
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, et al.
JCO Precision Oncology
|
March 12, 2026
Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study
Andrea Boutros, Matteo S Carlino, Raja Chaganti, et al.
Molecular Cancer Research : MCR
|
March 6, 2019
Somatic Hypermutation of the <i>YAP</i> Oncogene in a Human Cutaneous Melanoma
Xiaomeng Zhang, Jian Zhong Tang, Ismael A Vergara, et al.
Cancers
|
December 5, 2019
Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
Russell J Diefenbach, Jenny H Lee, Dario Strbenac, et al.
Science Signaling
|
August 20, 2015
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale, Robert N Jorissen, Frederic Z Li, et al.
Nature Communications
|
April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.
Oncotarget
|
November 3, 2015
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Elin S Gray, Helen Rizos, Anna L Reid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2020
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
Jenny H Lee, Alexander M Menzies, Matteo S Carlino, et al.
Cancer Research
|
October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma
Y N Vashisht Gopal, Helen Rizos, Guo Chen, et al.
Page
of 14